CLSI M45A

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline, M45-A

Clinical and Laboratory Standards Institute, 05/30/2006

Publisher: CLSI

File Format: PDF

$143.00$287.41

Description

Published:30/05/2006

Pages:76

CLSI M45A provides guidance to clinical microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI/NCCLS documents M2, M7, or M11. The tabular information in this document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in this guideline.

More CLSI standard pdf

CLSI H18-A3

Procedures for the Handling and Processing of Blood Specimens; Approved Guideline

$111.00 $223.88

CLSI HS01A2

A Quality Management System Model for Health Care; Approved Guideline, HS01-A2

$137.00 $274.67

CLSI C45-A

Measurement of Free Thyroid Hormones; Approved Guideline , C45AE

$108.00 $217.61

CLSI GP45-A

Studies to Evaluate Patient Outcomes; Approved Guideline, GP45AE

$103.00 $206.11